Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry.

MLA

Rifkin-Zybutz, Raphael, et al. “Clinical Outcome Data of Anxiety Patients Treated with Cannabis-Based Medicinal Products in the United Kingdom: A Cohort Study from the UK Medical Cannabis Registry.” Psychopharmacology, vol. 240, no. 8, Aug. 2023, pp. 1735–45. EBSCOhost, https://doi.org/10.1007/s00213-023-06399-3.

APA

Rifkin-Zybutz, R., Erridge, S., Holvey, C., Coomber, R., Gaffney, J., Lawn, W., Barros, D., Bhoskar, U., Mwimba, G., Praveen, K., Symeon, C., Sachdeva-Mohan, S., Rucker, J. J., & Sodergren, M. H. (2023). Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry. Psychopharmacology, 240(8), 1735–1745. https://doi.org/10.1007/s00213-023-06399-3

Chicago

Rifkin-Zybutz, Raphael, Simon Erridge, Carl Holvey, Ross Coomber, Jessica Gaffney, Will Lawn, Daniela Barros, et al. 2023. “Clinical Outcome Data of Anxiety Patients Treated with Cannabis-Based Medicinal Products in the United Kingdom: A Cohort Study from the UK Medical Cannabis Registry.” Psychopharmacology 240 (8): 1735–45. doi:10.1007/s00213-023-06399-3.